Viona Pharmaceuticals Inc. is a generic pharmaceutical company based in Cranford, NJ with a mission to provide high quality, affordable generic products and excellent service. As a wholly owned indirect subsidiary of Zydus Lifesciences Limited, India, Viona benefits from being part of a fully integrated, global healthcare provider. The company's vast portfolio includes oral solids and topicals, and it boasts a strong development pipeline. Founded in 2018, Viona operates in the Manufacturing and Pharmaceutical industries, with its headquarters located in the United States. As of now, there is no public information available about Viona Pharmaceuticals Inc.'s last investment or the investors involved. However, with its focus on providing affordable generic products and its association with Zydus Lifesciences Limited, a globally recognized healthcare provider, Viona presents an intriguing opportunity for potential venture capital investment. The company's commitment to high quality and affordability aligns with current trends in the pharmaceutical market, making it a compelling prospect for interested investors looking to tap into the generic pharmaceutical segment.
There is no investment information
No recent news or press coverage available for Viona Pharmaceuticals Inc..